3,249
Views
99
CrossRef citations to date
0
Altmetric
Original Research Articles

Different EV enrichment methods suitable for clinical settings yield different subpopulations of urinary extracellular vesicles from human samples

, , , , , , , , , , , , & show all
Article: 29497 | Received 21 Aug 2015, Accepted 23 Jan 2016, Published online: 15 Feb 2016

References

  • Hoorn EJ, Pisitkun T, Zietse R, Gross P, Frokiaer J, Wang NS, etal. Prospects for urinary proteomics: exosomes as a source of urinary biomarkers. Nephrology. 2005; 10: 283–90.
  • Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA. 2004; 101: 13368–73.
  • Pisitkun T, Johnstone R, Knepper MA. Discovery of urinary biomarkers. Mol Cell Proteomics. 2006; 5: 1760–71.
  • Miranda KC, Bond DT, McKee M, Skog J, Paunescu TG, Da Silva N, etal. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int. 2010; 78: 191–9.
  • Gamez-Valero A, Lozano-Ramos SI, Bancu I, Lauzurica-Valdemoros R, Borras FE. Urinary extracellular vesicles as source of biomarkers in kidney diseases. Front Immunol. 2015; 6: 6.
  • Gonzalez E, Falcon-Perez JM. Cell-derived extracellular vesicles as a platform to identify low-invasive disease biomarkers. Expert Rev Mol Diagn. 2015; 15: 907–23.
  • Saenz-Cuesta M, Arbelaiz A, Oregi A, Irizar H, Osorio-Querejeta I, Munoz-Culla M, etal. Methods for extracellular vesicles isolation in a hospital setting. Front Immunol. 2015; 6: 50. [PubMed Abstract] [PubMed CentralFull Text].
  • Alvarez ML, Khosroheidari M, Kanchi Ravi R, DiStefano JK. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int. 2012; 82: 1024–32.
  • Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P, etal. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012; 10: e1001450.
  • Gyorgy B, Szabo TG, Pasztoi M, Pal Z, Misjak P, Aradi B, etal. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011; 68: 2667–88.
  • Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010; 73: 1907–20.
  • Kowal J, Tkach M, Thery C. Biogenesis and secretion of exosomes. Curr Opin Cell Biol. 2014; 29: 116–25.
  • Ohno S, Ishikawa A, Kuroda M. Roles of exosomes and microvesicles in disease pathogenesis. Adv Drug Deliv Rev. 2013; 65: 398–401.
  • Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol Genet. 2013; 200: 373–83.
  • Crescitelli R, Lasser C, Szabo TG, Kittel A, Eldh M, Dianzani I, etal. Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles. 2013; 2: 20677. http://dx.doi.org/10.3402/jev.v2i0.20677.
  • Echevarria J, Royo F, Pazos R, Salazar L, Falcon-Perez JM, Reichardt NC. Microarray-based identification of lectins for the purification of human urinary extracellular vesicles directly from urine samples. Chem Bio Chem. 2014; 15: 1621–6.
  • Gerlach JQ, Kruger A, Gallogly S, Hanley SA, Hogan MC, Ward CJ, etal. Surface glycosylation profiles of urine extracellular vesicles. PLoS One. 2013; 8: e74801.
  • Perez A, Loizaga A, Arceo R, Lacasa I, Rabade A, Zorroza K, etal. A pilot study on the potential of RNA-associated to urinary vesicles as a suitable non-invasive source for diagnostic purposes in bladder cancer. Cancers. 2014; 6: 179–92.
  • Royo F, Falcon-Perez JM. Liver extracellular vesicles in health and disease. J Extracell Vesicles. 2012; 1: 18825. http://dx.doi.org/10.3402/jev.v1i0.18825.
  • Musante L, Tataruch D, Gu D, Benito-Martin A, Calzaferri G, Aherne S, etal. A simplified method to recover urinary vesicles for clinical applications, and sample banking. Sci Rep. 2014; 4: 7532.
  • Cheruvanky A, Zhou H, Pisitkun T, Kopp JB, Knepper MA, Yuen PS, etal. Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. Am J Physiol Renal Physiol. 2007; 292: F1657–61.
  • Momen-Heravi F, Balaj L, Alian S, Trachtenberg AJ, Hochberg FH, Skog J, etal. Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles. Front Physiol. 2012; 3: 162. [PubMed Abstract] [PubMed CentralFull Text].
  • Musante L, Saraswat M, Duriez E, Byrne B, Ravida A, Domon B, etal. Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment. PLoS One. 2012; 7: e37279.
  • Kosanovic M, Jankovic M. Isolation of urinary extracellular vesicles from Tamm-Horsfall protein-depleted urine and their application in the development of a lectin-exosome-binding assay. Biotechniques. 2014; 57: 143–9. [PubMed Abstract].
  • Duijvesz D, Versluis CY, van der Fels CA, Vredenbregt-van den Berg MS, Leivo J, Peltola MT, etal. Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer. Int J Cancer. 2015; 137: 2869–78.
  • Overbye A, Skotland T, Koehler C, Thiede B, Seierstad T, Berge V, etal. Identification of prostate cancer biomarkers in urinary exosomes. Oncotarget. 2015; 6: 30357–76. [PubMed Abstract].
  • Isin M, Uysaler E, Ozgur E, Koseoglu H, Sanli O, Yucel OB, etal. Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease. Front Genet. 2015; 6: 168. [PubMed Abstract] [PubMed CentralFull Text].
  • Nilsson J, Skog J, Nordstrand A, Baranov V, Mincheva-Nilsson L, Breakefield XO, etal. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer. 2009; 100: 1603–7.